The CARE Program can be used to identify patients who are at increased risk for cancer or who qualify for hereditary cancer testing. Customized cancer screening and risk reduction plans can then be made, which may lead to earlier detection and decreased risks. Best of all, there is information and support for patients and providers at every step.
High Risk Identification
CARE utilizes a secure HIPAA-compliant application to collect and analyze patients’ medical information and family history prior to in-person visits. The CARE Program can be used to identify patients who are at increased risk for breast cancer and/or who qualify for hereditary cancer testing.
Breast Cancer Risk
The CARE Program’s digital tools analyze medical and family history information to provide a patient’s risk of developing breast cancer in the next 10 years. If that risk is 20%[1] or higher, increased breast cancer screening, including annual breast MRI, may be appropriate. The goal is to detect breast cancer earlier, when it is easier to treat. In some cases, risk reducing options may also be appropriate.
1. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR, Monticciolo, Debra L. et al., Journal of the American College of Radiology, Volume 15, Issue 3, 408 - 414
Hereditary Cancer Testing
The CARE Program’s digital tools analyze medical history, family history, and previous genetic test results and weigh this information against national guidelines to determine whether a patient meets criteria for hereditary cancer testing. Someone born with inherited risk for cancer may qualify for increased cancer screening (e.g. earlier mammograms, more frequent colonoscopies) or options to reduce their risk (e.g. medications, risk-reducing procedures). This information may also be important for family members who qualify for hereditary cancer testing.
Providers
Consistently collect and analyze patient medical and family history
Enable patient education and informed consent
Identify patients and families who qualify for hereditary cancer testing
Implement tailored cancer screening and risk reduction plans that are guideline-concordant
Patients
Access resources to better understand your risks and genetic testing options
Speak with a genetic counselor to discuss your genetic test results
Customize cancer screening and risk reduction plans
Learn whether family members may also be at risk
How Does CARE Work?
An end-to-end program for identifying most at-risk patients, with information and support for patients and clinicians at every step.
Identification
Using digital tools to collect/analyze patient health data
Pre-Test Education
Demonstrating how genetic testing can guide health and family planning and prenatal care
Genetic Testing
Streamlining ordering through Ambry for qualified individuals
Results Delivery
Delivering results to the ordering provider and next steps for patients, including customizable options for patient result disclosure
Post-Test Genetic Counseling
Making counseling available by telehealth to all patients who have testing, at no charge to patient
Documentation
Improving patient and provider experience with transparency at each step